Parenteral Drugs | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
2,578
2,511
2,473
2,297
2,171
321
Cost of Goods Sold (COGS) incl. D&A
2,548
2,178
2,576
2,242
2,026
955
Gross Income
30
333
103
56
145
634
SG&A Expense
933
534
504
394
598
233
EBIT
1,095
281
702
424
453
867
Unusual Expense
567
4
-
-
-
-
Non Operating Income/Expense
627
123
129
23
16
14
Interest Expense
602
703
699
858
975
961
Pretax Income
466
864
1,269
1,255
1,412
1,814
Income Tax
14
187
104
103
223
335
Consolidated Net Income
452
677
1,165
1,152
1,189
1,479
Net Income
452
677
1,165
1,152
1,189
1,479
Net Income After Extraordinaries
452
677
1,165
1,152
1,189
1,479
Net Income Available to Common
452
677
1,165
1,152
1,189
1,479
EPS (Basic)
15.15
22.69
39.09
38.64
39.89
49.61
Basic Shares Outstanding
30
30
30
30
-
-
EPS (Diluted)
15.15
22.69
39.09
38.64
-
-
Diluted Shares Outstanding
30
30
30
30
-
-
EBITDA
908
29
474
175
211
176
Other Operating Expense
191
80
95
86
-
-
Non-Operating Interest Income
37
1
3
3
-
-

About Parenteral Drugs

View Profile
Address
Shree Ganesh Chambers
Indore Madhya Pradesh 452001
India
Employees -
Website http://www.pdindia.com
Updated 07/08/2019
Parenteral Drugs (India) Ltd. is a pharmaceutical company, which engages in the research, production, and manufacturing of pharmaceutical products. It includes intravenous infusion, tablets, capsules, liquids syrups, and injections. The company was founded on December 13, 1983 and is headquartered in Indore, India.